Masataka Ohta

Title: Masataka Ohta: Innovator in G Protein-Coupled Receptor Research

Introduction

Masataka Ohta is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of G protein-coupled receptors. With a total of 3 patents to his name, Ohta's work has implications for drug development and signal transduction research.

Latest Patents

Ohta's latest patents focus on guanosine triphosphate (GTP) binding protein-coupled receptor proteins that bind histamine and are expressed in the brain. One of his notable patents involves isolating a full-length cDNA encoding a human-derived G protein-coupled receptor protein by screening a human hippocampus library. Additionally, a rat-derived cDNA corresponding to the human-derived cDNA is also isolated. The proteins encoded by these cDNAs exhibit the ability to lower intracellular cAMP concentration when stimulated with histamine. These proteins serve as valuable tools for screening ligands and candidate compounds for drugs that can regulate signal transduction.

Career Highlights

Masataka Ohta is currently associated with Banyu Pharmaceutical Co. Ltd., where he continues to advance his research in the field. His work has garnered attention for its potential applications in pharmacology and therapeutic development.

Collaborations

Ohta has collaborated with notable colleagues, including Takao Nakamura and Yusuke Hidaka, contributing to a dynamic research environment that fosters innovation.

Conclusion

Masataka Ohta's contributions to the field of G protein-coupled receptor research highlight his role as an influential inventor. His patents and ongoing work at Banyu Pharmaceutical Co. Ltd. continue to pave the way for advancements in drug discovery and signal transduction.